VeDA Names Recipients of Champion of Vestibular Medicine Award Initiative
The Vestibular Disorders Association (VeDA) has named the recipients of its 2024 Lifetime Achievement Awards.
The Vestibular Disorders Association (VeDA) has named the recipients of its 2024 Lifetime Achievement Awards.
Treating hearing loss is an important aspect of reducing the risk of balance issues in the broader adult population.
Otolith Labs’ noninvasive vestibular system masking (nVSM) technology is designed to provide acute treatment for vestibulogenic vertigo.
The objectives of this study were to describe a potentially underappreciated pathology for post-traumatic persistent intractable dizziness and third window syndrome as well as the methods to diagnose and surgically manage this disorder.
Ménière’s disease is almost exclusively reported in adults, with less than 3% of cases estimated to occur in children younger than 18 years old.
On August 20, 2020, the Company received a letter from Nasdaq stating that because the Company’s shares had a closing bid price at or above $1.00 per share for a minimum of ten (10) consecutive business days, the Company’s stock had regained compliance with the Minimum Bid Price Requirement for continued listing on Nasdaq, and that the matter is now closed.